BORAK KOSONG, CHAT, GOSSIP, ULASAN, LUAHAN, DAN BERSANTAI VOLUME 41

seribulan

    NEWS
    02 December 2021

How bad is Omicron? What scientists know so far
COVID researchers are working at breakneck speed to learn about the variant’s transmissibility, severity and ability to evade vaccines.

    Ewen Callaway & Heidi Ledford

    Twitter

Facebook
Email

A nurse puts on her personal protective equipment

South Africa is dealing with a large uptick in COVID cases, driven by a new, heavily mutated variant called Omicron.Credit: Guillem Sartorio/AFP/Getty

Barely a week has elapsed since scientists in Botswana and South Africa alerted the world to a fast-spreading new SARS-CoV-2 variant now known as Omicron. Researchers worldwide are racing to understand the threat that the variant — now confirmed in more than 20 countries — poses to the world. Yet it might take scientists weeks to paint a more complete picture of Omicron, and to gain an understanding of its transmissibility and severity, as well as its potential to evade vaccines and cause reinfections.

Heavily mutated Omicron variant puts scientists on alert

“Wherever I go, everyone says: tell us more about Omicron,” says Senjuti Saha, molecular microbiologist and director of the Child Health Research Foundation in Dacca, Bangladesh. “There is so little understanding of what’s going on, and that’s true, even for scientists.”

Nature rounds up what scientists know so far about the Omicron variant.
How fast is Omicron spreading?

Omicron’s rapid rise in South Africa is what worries researchers most, because it suggests the variant could spark explosive increases in COVID-19 cases elsewhere. On 1 December, South Africa recorded 8,561 cases, up from the 3,402 reported on 26 November and several hundred per day in mid-November, with much of the growth occurring in Gauteng Province, home to Johannesburg.

Epidemiologists measure an epidemic’s growth using R, the average number of new cases spread by each infection. In late November, South Africa’s National Institute for Communicable Disease (NICD) in Johannesburg determined that R was above 2 in Gauteng. That level of growth was last observed in the early days of the pandemic, Richard Lessels, an infectious-disease physician at KwaZulu-Natal University in Durban, South Africa, told a press briefing last week.

Gauteng’s R value was well below 1 in September — when Delta was the predominant variant and cases were falling — suggesting that Omicron has the potential to spread much faster and infect vastly more people than Delta, says Tom Wenseleers, an evolutionary biologist at KU-Leuven in Belgium. Based on the rise in COVID-19 cases and sequencing data, Wenseleers estimates that Omicron can infect 3 to 6 times as many people as Delta, over the same time period. “That’s a huge advantage for the virus — but not for us,” he adds.

Researchers will be watching how Omicron spreads in other parts of South Africa and globally to get a better read on its transmissibility, says Christian Althaus, a computational epidemiologist at the University of Bern, Switzerland. Heightened surveillance in South Africa could cause researchers to overestimate Omicron’s fast growth. But if this pattern is repeated in other countries, it’s very strong evidence that Omicron has a transmission advantage, adds Althaus. “If it doesn’t happen, for example, in European countries, it means things are a bit more complex and strongly depend on the immunological landscape. So we have to wait.”

Although genome sequencing is needed to confirm Omicron cases, some PCR tests can pick up a hallmark of the variant that distinguishes it from Delta. On the basis of this signal, there are preliminary signs that cases, although extremely low in number, are rising in the United Kingdom. “That’s certainly not what we want to see right now and suggests that Omicron could indeed also have a transmission advantage in the UK,” Althaus adds.
Can Omicron overcome immunity from vaccines or infection?

The variant’s swift rise in South Africa hints that it has some capacity to overcome immunity. Around one-quarter of South Africans are fully vaccinated, and it’s likely that a large fraction of the population was infected with SARS-CoV-2 in earlier waves, says Wenseleers, based on heightened death rates since the start of the pandemic.

In this context, Omicron’s success in southern Africa might be due largely to its capacity to infect people who recovered from cases of COVID-19 caused by Delta and other variants, as well as those who’ve been vaccinated. A 2 December preprint1 from researchers at the NICD found that reinfections in South Africa have increased, as Omicron has spread. “Unfortunately, this is the perfect environment for immune escape variants to develop,” says Althaus.

How well the variant spreads elsewhere might depend on factors such as vaccination and prior infection rates, says Aris Katzourakis, an expert in viral evolution at the University of Oxford, UK. “If you throw it into the mix in a highly vaccinated population that has given up on other control measures, it might have the edge there.”

Omicron-variant border bans ignore the evidence, say scientists

Researchers want to measure Omicron’s ability to evade immune responses and the protection they offer. For instance, a team led by Penny Moore, a virologist at the NICD and the University of Witwatersrand in Johannesburg, is measuring the ability of neutralizing, or virus-blocking, antibodies triggered by previous infection and vaccination to stop Omicron from infecting cells, in a laboratory test. Her team is making ‘pseudovirus’ particles — an engineered version of HIV that uses SARS-CoV-2’s spike protein to infect cells — to match Omicron, which harbours as many as 32 changes to spike.

Another South Africa-based team, led by virologist Alex Sigal at the African Health Research Institute in Durban, is conducting similar tests on virus-neutralizing antibodies using infectious SARS-CoV-2 particles. So is a team led by Pei-Yong Shi, a virologist at the University of Texas Medical Branch in Galveston, who is collaborating with Pfizer–BioNtech to determine how its vaccine holds up against Omicron. “I was really very concerned when I saw the constellation of mutations in the spike,” he says. “We just have to wait for the results.”

Previous studies of Omicron’s spike mutations — particularly in the region that recognizes receptors on human cells — suggest that the variant will blunt the potency of neutralizing antibodies. For instance, in a September 2021 Nature paper2, a team co-led by Paul Bieniasz, a virologist at Rockefeller University in New York City, engineered a highly mutated version of spike — in a virus incapable of causing COVID-19 — that shares numerous mutations with Omicron. The ‘polymutant spike’ proved fully resistant to neutralizing antibodies from most of the people they tested who had either received two doses of an RNA vaccine or recovered from COVID-19. With Omicron, “we expect there to be a significant hit,” says Bieniasz.
People wait to be inoculated at a vaccination centre

Vaccines’ potency against the Omicron variant could be blunted, early analyses suggest.Credit: Horacio Villalobos/Corbis/Getty
How will vaccines fare against Omicron?

If Omicron can dodge neutralizing antibodies, it does not mean that immune responses triggered by vaccination and prior infection will offer no protection against the variant. Immunity studies suggest that relatively low levels of neutralizing antibodies may protect people from severe forms of COVID-19, says Miles Davenport, an immunologist at the University of New South Wales in Sydney, Australia.

Other parts of the immune system, particularly T cells, may be less affected by Omicron’s mutations than are antibody responses. Researchers in South Africa plan to measure the activity of T cells and another immune player called natural killer cells, which may be especially important for protection against severe COVID-19, says Shabir Madhi, a vaccinologist at the University of Witwatersrand.

Madhi, who has led COVID-19 vaccine trials in South Africa, is also part of efforts to conduct epidemiological studies of vaccines’ effectiveness against Omicron. There are anecdotal reports of breakthrough infections in all three vaccines that have been administered in South Africa – Johnson & Johnson, Pfizer–BioNtech and Oxford–AstraZeneca. But Madhi says researchers will want to quantify the level of protection provided by vaccines, as well as prior infection against Omicron.

He suspects that the results will be reminiscent of how the AstraZeneca–Oxford vaccine performed against the Beta variant, an immune-evading variant that was identified in South Africa in late 2020. A study led by Madhi found that the vaccine offered little protection against mild and moderate cases in relatively young people, while a real-world analysis in Canada showed greater than 80% protection against hospitalization.

If Omicron behaves similarly, Madhi says, “we’re going to see a surge of cases. We’re going to see lots of breakthrough infections, lots of reinfections. But there’s going to be this unhinging of the case rate in the community compared to the hospitalization rate”. Early reports suggest that most breakthrough infections with Omicron have been mild, says Madhi. “For me, that is a positive signal.”
Will current boosters improve protection against Omicron?

The threat of Omicron has prompted some rich countries, such as the United Kingdom, to accelerate and broaden the roll-out of COVID vaccine booster doses. But it’s not yet clear how effective these additional doses will be.

Third doses supercharge neutralizing-antibody levels, and it’s likely that this will provide a bulwark against Omicron’s ability to evade these antibodies, says Bieniasz. His team’s work on the polymutant spike found that people who had recovered from COVID-19 months before receiving their jabs had antibodies still capable of blocking the mutant spike. To Bieniasz, those results suggest that people with repeated exposure to SARS-CoV-2’s spike protein, be it through infection or a booster dose, are “quite likely to have neutralizing activity against Omicron.”
Does Omicron cause milder or more severe disease than previous variants?

Early reports linked Omicron with mild disease, raising hopes that the variant might be less severe than some of its predecessors. But these reports — which are often based on anecdotes or scant scraps of data — can be misleading, cautions Müge Çevik, an infectious disease specialist at the University of St Andrews, UK. “Everyone is trying to find some data that could guide us,” she says. “But it’s very difficult at the moment.”

A major challenge when assessing whether a variant’s severity is controlling for the many confounding variables that can influence the course of disease, particularly when outbreaks are geographically localized. For example, reports of mild disease from Omicron infection in South Africa could reflect the fact that the country has a relatively young population, many of whom have already been exposed to SARS-CoV-2.

During the early days of the Delta outbreak, there were reports that the variant was causing more serious illness in children than other variants — an association that dissolved once more data were collected, Çevik says.

Researchers will be looking for data on Omicron infections in other countries. This geographical spread, and a larger sample size as cases accrue, will give researchers a better idea of how generalizable the early anecdotes might be.Ultimately, researchers will want to conduct case-controlled studies in which the demographics of people infected with Omicron are carefully matched to the demographics of a comparison group. This will allow scientists to better control for important factors, such as age, vaccination status and health conditions. Data from both groups will need to be collected contemporaneously, because the number of hospitalizations can be influenced by overall hospital capacity in a region.

And, crucially, researchers will need to control for the level of economic deprivation. A rapidly spreading new variant may reach vulnerable groups more rapidly, Çevik says, by nature of their work or living conditions. And such groups often experience more severe disease.

All of this will take time. “I think the severity question will be one of the last bits that we’ll be able to untangle,” she says. “That’s how it happened with Delta.”
Where has Omicron spread and how are scientists tracking it?

So far, Omicron has been detected in more than 20 countries, a number that has been steadily ticking up as efforts to track the variant increase around the world.

But the capacity to rapidly sequence viruses from positive COVID tests is concentrated in wealthy countries, meaning that early data on Omicron’s spread will be skewed.

Surveillance efforts in Brazil and some other countries are taking advantage of a distinctive result on particular PCR tests for COVID that could allow them to pinpoint potential Omicron cases for sequencing, says virologist Renato Santana at the Federal University of Minas Gerais in Brazil. The test looks for segments of three viral genes, one of which is the gene that encodes for the spike protein. Mutations in Omicron’s spike gene prevent its detection in the test, meaning that samples containing the variant will only test positive for two of the genes.

Even so, not everyone uses that kit and it could take some time before Omicron’s spread is fully mapped. Despite some guidelines urging countries to sequence 5% of their samples that test positive for SARS-CoV-2, few countries can afford to do so, says computational virologist Anderson Brito at the All for Health Institute in São Paulo, Brazil.And Brito worries that the travel bans some countries enacted against South Africa and other southern African nations in the wake of its Omicron discovery could discourage governments from sharing their surveillance data. “We are punishing those who did a good job,” he says.

In Bangladesh, which sequences about 0.2% of positive coronavirus samples, researchers would be eager to ramp up genomic surveillance to monitor for Omicron and other emerging variants, says molecular microbiologist Senjuti Saha, a molecular microbiologist and director of the Child Health Research Foundation in Dhaka. But resources are limited. Bangladesh is recovering from a large dengue outbreak, she adds. “In the Global South, we are all worried about COVID, but let’s not forget our endemic diseases,” Saha says. “We can only do so many.”

doi: https://doi.org/10.1038/d41586-021-03614-z
References

    1.

    Schmidt, F. et al. Nature https://doi.org/10.1038/s41586-021-04005-0 (2021).

S.African doctor says patients with Omicron variant have "very mild" symptoms
By Promit Mukherjee



JOHANNESBURG, Nov 28 (Reuters) - A South African doctor who was one of the first to suspect a different coronavirus strain among patients said on Sunday that symptoms of the Omicron variant were so far mild and could be treated at home.

Dr. Angelique Coetzee, a private practitioner and chair of South African Medical Association, told Reuters that on Nov. 18 she noticed seven patients at her clinic who had symptoms different from the dominant Delta variant, albeit "very mild".

Now designated Omicron by the World Health Organization, the variant was detected and announced by South Africa's National Institute of Communicable Diseases (NICD) on Nov. 25 from samples taken from a laboratory from Nov. 14 to Nov. 16.

Coetzee said a patient on Nov. 18 reported at her clinic being "extremely fatigued" for two days with body aches and headache.

"Symptoms at that stage was very much related to normal viral infection. And because we haven't seen COVID-19 for the past eight to 10 weeks, we decided to test," she said, adding that the patient and his family turned out to be positive.

On the same day, more patients came in with similar symptoms, which was when she realised there was "something else going on." Since then, she's seen two to three patients a day.
International check-in counters stand empty as several airlines stopped flying out of South Africa, amidst the spread of the new SARS-CoV-2 variant Omicron, at O.R. Tambo International Airport in Johannesburg, South Africa, November 28, 2021. REUTERS/ Sumaya Hisham
A passenger in a taxi wears a face mask with colours of the South African flag after the announcement of a British ban on flights from South Africa because of the detection of a new coronavirus disease (COVID-19) variant, in Soweto, South Africa, November 26, 2021. REUTERS/Siphiwe Sibeko

Passengers wait for confirmation of flights outside the Swissport Ticket Sales counter as several airlines stopped flying out of South Africa, amidst the spread of the new SARS-CoV-2 variant Omicron, at O.R. Tambo International Airport in Johannesburg, South Africa, November 28, 2021. REUTERS/ Sumaya Hisham


A passenger in a taxi wears a face mask with colours of the South African flag after the announcement of a British ban on flights from South Africa because of the detection of a new coronavirus disease (COVID-19) variant, in Soweto, South Africa, November 26, 2021. REUTERS/Siphiwe Sibeko

"We have seen a lot of Delta patients during the third wave. And this doesn't fit in the clinical picture," she said, adding she alerted NICD on the same day with the clinical results.

"Most of them are seeing very, very mild symptoms and none of them so far have admitted patients to surgeries. We have been able to treat these patients conservatively at home," she said.

Coetzee, who is also on the Ministerial Advisory Committee on Vaccines, said unlike the Delta so far patients have not reported loss of smell or taste and there has been no major drop in oxygen levels with the new variant.

Her experience so far has been that the variant is affecting people who are 40 or younger. Almost half of the patients with Omicron symptoms that she treated were not vaccinated.

"The most predominant clinical complaint is severe fatigue for one or two days. With them, the headache and the body aches and pain."

The news of the new variant emerging from South Africa prompted a swift reaction from several countries, including Britain, which on Friday imposed a travel ban on several southern African countries with immediate effect, a decision South Africa has strongly contested. read more

Since Friday, many countries have also banned air travel to and from South Africa, including the United States, other European countries, and some Asian nations.

BlackOpium

seribulan replied at 3-12-2021 03:55 PM

Ni countries yang dah ada variant baru tu ke?

BlackOpium

seribulan replied at 3-12-2021 03:59 PM
NEWS
    02 December 2021

Rasanya ada terbaca jugak kat SA tu macam biasa je. Kes variant baru pun doktor rileks je suruh patient kuarantin dekat rumah.
My friend ni doctor. Dia pesan jangan panik, sentiasa follow SOP, sanitize and elakkan tempat crowded.

seribulan

BlackOpium replied at 3-12-2021 03:02 PM
Ni countries yang dah ada variant baru tu ke?

Sebelum varian rasanya...tengah krup krap biji gajus...

seribulan

BlackOpium replied at 3-12-2021 03:08 PM
Rasanya ada terbaca jugak kat SA tu macam biasa je. Kes variant baru pun doktor rileks je suruh pa ...

Balik rumah...tanggal baju...basuh...bla bla bla tu...

seribulan

Kes baharu COVID-19 Selangor 3.12.2021 sehingga 12.00 tengahari – 1719 kes (1715 komuniti, 4 penjara)
???? GOMBAK 201
Batu 94
Saringan Bergejala 2
Saringan Kontak Rapat 92
Hulu Kelang 29
Saringan Bergejala 2
Saringan Kontak Rapat 27
Kuang 25
Saringan Bergejala 1
Saringan Kontak (Kluster Lorong Melati) 2
Saringan Kontak Rapat 22
Rawang 33
Saringan Kontak Rapat 32
Saringan Postmortem 1
Setapak 20
Saringan Kontak Rapat 20
???? HULU LANGAT 346
Ampang 57
Saringan Bergejala 26
Saringan Kendiri 1
Saringan Kontak Rapat 30
Beranang 14
Saringan Bergejala 5
Saringan Kendiri 1
Saringan Kontak (Kluster Industri Perusahaan Lima Beranang) 1
Saringan Kontak Rapat 7
Cheras 67
Saringan Bergejala 27
Saringan Kendiri 1
Saringan Kontak Rapat 37
Saringan Pekerja 1
Saringan Pre-Admission 1
Hulu Langat 17
Saringan Bergejala 7
Saringan Kendiri 1
Saringan Kontak Rapat 9
Kajang 156
Saringan Bergejala 55
Saringan Bergejala (Kluster Industri Jln Kemajuan Bangi 2) 1
Saringan Bergejala (Kluster Industri Persiaran Usahawan Tiga 2) 2
Saringan Kontak (Kluster Industri Persiaran Kemajuan) 1
Saringan Kontak (Kluster Industri Persiaran Usahawan Tiga 2) 2
Saringan Kontak (Kluster Jln Kajang Perdana 3/1) 1
Saringan Kontak Rapat 90
Saringan Pekerja 1
Saringan Pre-Admission 2
Saringan SARI 1
Semenyih 33
Saringan Bergejala 13
Saringan Kontak Rapat 19
Saringan Pre-Admission 1
Penjara 2
Saringan OKT 2
???? HULU SELANGOR 101
Ampang Pechah 6
Saringan Bergejala 1
Saringan Kontak Rapat 5
Batang Kali 17
Saringan Bergejala 9
Saringan Kontak Rapat 8
Hulu Bernam 2
Saringan Kontak Rapat 2
Hulu Yam 1
Saringan Kontak Rapat 1
Kalumpang 1
Saringan Kontak Rapat 1
Kerling 2
Saringan Kontak Rapat 2
Pertak 2
Saringan Kontak Rapat 2
Rasa 1
Saringan Bergejala 1
Serendah 69
Saringan Bergejala 42
Saringan Kontak Rapat 27
???? KLANG 166
Kapar 32
Saringan Bergejala 7
Saringan Kontak Rapat 25
Klang 134
Saringan Bergejala 38
Saringan Kontak Rapat 74
Saringan Pekerja 22
???? KUALA LANGAT 106
Bandar 2
Saringan Kontak Rapat 2
Batu 4
Saringan Bergejala 1
Saringan Kontak Rapat 3
Morib 1
Saringan Bergejala 1
Tanjung 12 (1) 40
Saringan Bergejala 14
Saringan Kendiri 1
Saringan Kontak Rapat 22
Saringan Pekerja 2
Saringan Pekerja (Kluster Industri Dua Jln lapan Olak) 1
Tanjung 12 (2) 22
Saringan Bergejala 6
Saringan Kendiri 1
Saringan Kontak Rapat 3
Saringan Pekerja 2
Saringan Pekerja (Kluster Industri Jln Labohan Dagang-Nilai) 9
Saringan SARI 1
Telok Panglima Garang 35
Saringan Bergejala 15
Saringan Kontak Rapat 19
Saringan Pre-Admission 1
Penjara 2
Saringan OKT 2
???? KUALA SELANGOR 102
Api - Api 5
Saringan Bergejala 3
Saringan Kontak Rapat 2
Bestari Jaya 9
Saringan Bergejala 5
Saringan Kendiri 1
Saringan Kontak Rapat 3
Ijok 35
Saringan Bergejala 11
Saringan Bergejala (Kluster Industri Alam Jaya 2/4) 1
Saringan Kendiri 3
Saringan Kontak Rapat 17
Saringan Pekerja 2
Saringan Pre-Admission 1
Jeram 15
Saringan Bergejala 6
Saringan Kendiri 3
Saringan Kontak Rapat 5
Saringan Pekerja 1
Kuala Selangor 13
Saringan Bergejala 6
Saringan Kendiri 1
Saringan Kontak Rapat 6
Pasangan 1
Saringan Bergejala 1
Tanjung Karang 24
Saringan Bergejala 4
Saringan Kendiri 2
Saringan Kontak Rapat 17
Saringan Pekerja 1
???? PETALING 478
Bukit Raja 76
Saringan Bergejala 19
Saringan Kontak Rapat 56
Saringan Pekerja 1
Damansara 166
Saringan Bergejala 60
Saringan Kontak Rapat 103
Saringan Pekerja 3
Petaling 152
Saringan Bergejala 75
Saringan Kontak Rapat 73
Saringan Pekerja 4
Sungai Buloh 84
Saringan Bergejala 21
Saringan Kontak Rapat 61
Saringan Pekerja 2
???? SABAK BERNAM 59
Bagan Nakhoda Omar 6
Saringan Bergejala 1
Saringan Bergejala (Kluster Jln Semenanjung Bernam Tiga) 5
Panchang Bedena 26
Saringan Bergejala 13
Saringan Bergejala (Kluster Industri Batu 14 1/2 Panchang Bedena) 4
Saringan Kendiri 1
Saringan Kontak (Kluster Industri Batu 14 1/2 Panchang Bedena) 3
Saringan Kontak (Kluster Tebuk Pulai) 1
Saringan Kontak Rapat 4
Pasir Panjang 15
Saringan Bergejala 14
Saringan Kontak Rapat 1
Sabak 6
Saringan Bergejala 2
Saringan Kontak (Kluster Industri Batu 14 1/2 Panchang Bedena) 2
Saringan Kontak Rapat 2
Sungai Panjang 6
Saringan Bergejala 4
Saringan Bergejala (Kluster Dua Jln Sungai Panjang) 1
Saringan Kontak Rapat 1
???? SEPANG 160
Dengkil 111
Saringan Bergejala 11
Saringan Kendiri 3
Saringan Kontak (Kluster Persiaran Tasik) 42
Saringan Kontak Rapat 55
Labu 25
Saringan Bergejala 4
Saringan Kontak Rapat 21
Sepang 24
Saringan Bergejala 6
Saringan Kendiri 1
Saringan Kontak Rapat 17

seribulan

Kementerian Kesihatan Malaysia (KKM) ingin memaklumkan status terkini kes COVID-19 di Malaysia sehingga 3 Disember 2021 (jam 12:00 tengah hari);

• Kes sembuh : 5,301 kes (2,556,554 kes kumulatif, 96.5%);
• Kes baharu : 5,551 kes (2,649,578 kes kumulatif);
• Kes import : 23 kes (14 warganegara; 9 bukan warganegara);
• Kes tempatan : 5,528 kes [5,304 warganegara (95.9%); 224 bukan warganegara (4.1%)];
• Kes yang memerlukan rawatan di Unit Rawatan Rapi (ICU) : 499 kes (362 kes disahkan COVID-19 ;  137  kes disyaki, kemungkinan, dan kes dalam siasatan);
• Kes memerlukan bantuan pernafasan : 269 kes (157 kes disahkan COVID-19 ; 112 kes disyaki, kemungkinan, dan kes dalam siasatan);
• Jumlah kluster : 5,965 kluster;
• Jumlah kluster baharu : 6 kluster;
• Jumlah kluster yang telah tamat : 5,737 kluster; dan
• Jumlah kluster aktif : 228 kluster.
  

Daripada 5,551 kes harian yang dilaporkan pada hari ini;

• 78 kes (1.4 peratus) adalah kategori 3, 4, dan 5; dan
• 5,473 kes (98.6 peratus) lagi adalah terdiri daripada kategori 1 dan 2.
  

Perincian nilai RT mengikut negeri adalah seperti di Lampiran 1 yang disertakan bersama kenyataan media ini. Manakala, maklumat terperinci lain berkenaan situasi semasa jangkitan dan penularan COVID-19 di Malaysia akan dimuatnaik ke laman web COVIDNOW di https://covidnow.moh.gov.my. Data akan dikemaskini pada jam 12:00 tengah malam setiap hari.

KEMASUKAN PENGEMBARA KE MALAYSIA

Susulan arahan terkini YB Menteri Kesihatan Khairy Jamaluddin semasa Sidang Media Menteri Kesihatan hari ini, pengembara dari negara selain daripada lapan (8) buah negara yang dikenakan sekatan perjalanan sementara adalah dibenarkan untuk menyertai Gelembung Pelancongan Antarabangsa Langkawi. Selain daripada keperluan menjalankan ujian pengesanan COVID-19 menggunakan RT– PCR sekurang-kurangnya 72 jam sebelum bertolak ke Malaysia dan pada hari ketibaan, pengembara di Langkawi ini juga perlu menjalani ujian pengesanan COVID-19 menggunakan ujian RTK–Antigen (RTK-Ag) Professional pada hari ke-3 dan hari ke-5 selepas ketibaan.

Bagi pengembara yang membuat ujian di Langkawi pada hari ketibaan di pulau itu, mereka dibenarkan tinggal di hotel sementara menunggu keputusan ujian bagi mengelakkan perhimpunan ramai di Lapangan Terbang Antarabangsa Langkawi dan akan menerima perintah pengawasan dan pemerhatian (HSO) secara digital dalam aplikasi MySejahtera.

Manakala pengembara dari negara selain daripada lapan (8) buah negara yang dikenakan sekatan perjalanan sementara adalah dibenarkan memasuki Malaysia untuk melancong ke negeri-negeri selain Langkawi dengan mematuhi keperluan-keperluan di bawah:

• Perlu menjalani kuarantin wajib.
• Tempoh kuarantin bergantung kepada:
  
  • Status vaksinasi, iaitu tujuh (7) hari untuk individu dengan vaksin lengkap dan 10 hari sekiranya tidak menerima vaksin lengkap atau tidak menerima vaksin; DAN
  • Tempat kuarantin mengikut kelulusan yang diberikan oleh Home Quarantine Application (HQA), sama ada di rumah/tempat kediaman atau stesen kuarantin. Pengembara yang tidak diluluskan untuk menjalani kuarantin di rumah/tempat kediaman perlu membuat tempahan bilik di hotel yang dikenal pasti sebagai stesen kuarantin melalui MyTravelSafe di pautan https://safetravel.myeg.com.my/.
    
• Mereka yang datang dari negara berisiko tinggi dan menjalani kuarantin di rumah/tempat kediaman akan dipakaikan peranti pengesan digital (digital tracker). Negara berisiko tinggi ini akan dimaklumkan oleh KKM berdasarkan penilaian risiko yang dijalankan dari semasa ke semasa dan senarai akan diberikan kepada Pintu Masuk Antarabangsa (PMA) berkaitan untuk tindakan lanjut.
• Keperluan menjalani ujian pengesanan COVID-19 menggunakan RT-PCR semasa ketibaan dan pada hari ke-5 sekiranya kuarantin selama tujuh (7) hari atau pada hari ke-8 sekiranya kuarantin selama 10 hari.
• Penilaian risiko akan dilakukan ke atas pengembara pada hari ke-7 atau hari ke-10 sebelum pelepasan kuarantin.
  

Dengan pengisytiharan ini, maka kenyataan-kenyataan yang diumumkan sebelum ini adalah terbatal.

STATUS KLUSTER COVID-19 DI SEKOLAH SERI PUTERI

Kementerian Kesihatan Malaysia (KKM) ingin mengemaskini status kluster COVID-19 yang melibatkan warga sebuah sekolah di Cyberjaya iaitu Sekolah Seri Puteri dan dinamakan Kluster Persiaran Tasik. Kluster ini telah diumumkan pada 29 November 2021 apabila seramai lapan (8) kes disahkan postif COVID-19.

Susulan dari pengesanan kes-kes ini, Pejabat Kesihatan Daerah (PKD) Sepang telah melakukan saringan daripada 26 November 2021 sehingga 3 Disember 2021 ke atas 973 orang warga sekolah dan mendapati 135 kes baharu positif COVID-19. Ini menjadikan keseluruhan kes COVID-19 dalam kluster ini seramai 143 orang iaitu 114 murid, 19 guru, dan 10 kakitangan; dengan kadar serangan 14.7%.

Daripada 143 kes yang positif COVID-19, seramai 106 kes dalam kategori 1 manakala 35 kes yang lain adalah dalam kategori 2A dan dua (2) kes dalam kategori 2B (masing-masing seorang guru dan seorang murid). Kesemua kes positif ini berada dalam keadaan stabil. Kesemua murid yang positif COVID-19 dan seorang guru telah dimasukkan ke MAEPS untuk rawatan dan pemantauan lanjut.

Sementara itu, seramai 700 orang kontak rapat iaitu 603 murid, 59 orang guru, dan 38 orang kakitangan telah dikenal pasti.  Kontak rapat dalam kalangan murid dimasukkan ke stesen kuarantin iaitu di Institut Aminuddin Baki dan Institut Latihan Islam Malaysia. Manakala kontak rapat dalam kalangan guru dan kakitangan dikuarantin di rumah masing-masing.

Selain dari aktiviti saringan dan pengasingan kes positif dan kontak rapat, sekolah telah diarahkan ditutup sementara di bawah Seksyen 18 Akta Pencegahan dan Pengawalan Penyakit Berjangkit 1988 [Akta 342] bagi tujuan pembersihan dan disinfeksi. Satu sesi taklimat dan penerangan kepada Persatuan Ibu Bapa dan Guru sekolah tersebut telah diadakan. Pemantauan berterusan akan dijalankan bagi memastikan kluster ini terkawal.

NASIHAT KESIHATAN BERKAITAN COVID-19

KKM juga ingin menasihati orang ramai termasuk individu-individu yang telah menerima vaksin COVID-19 agar terus mematuhi saranan serta nasihat-nasihat kesihatan yang sering ditekankan iaitu;

• Elakkan 3S: (elakkan kawasan yang sesak, sempit dan sembang dengan jarak yang dekat);
• Amalkan 3W: (Amalkan Wash, Wear dan Warn); dan
• Sentiasa memakai pelitup muka di kawasan awam yang tertutup. Pemakaian pelitup muka berganda adalah digalakkan.
  

Patuhlah kepada Prosedur Operasi Standard (SOP) sebagai norma baharu dan dapatkan vaksin COVID-19 bagi mengurangkan risiko jangkitan yang serius, bilangan kes kematian sekaligus membina imuniti kelompok. Dengan pengambilan vaksin, kita dapat melindungi orang di sekeliling daripada kemungkinan jangkitan COVID-19. Dengan imuniti kelompok yang terbentuk, kumpulan yang belum layak diberi imunisasi seperti kanak-kanak dapat dilindungi. Perlindungan untuk semua bermula daripada diri kita.

KKM akan terus memantau perkembangan kejadian jangkitan di dalam negara, dan juga luar negara melalui maklumat yang diperolehi daripada pihak WHO. KKM akan memastikan langkah pencegahan dan kawalan yang sewajarnya dilaksanakan secara berterusan.

Sekian, terima kasih.

TAN SRI DATO’ SERI DR. NOOR HISHAM ABDULLAH

KETUA PENGARAH KESIHATAN MALAYSIA

3 Disember 2021 @ 7:00 petang.

LAMPIRAN 1

NILAI RT MENGIKUT NEGERI

BERDASARKAN KES YANG DILAPORKAN

PADA 2 DISEMBER 2021

NEGERI	NILAI R[size=12.375px]T
PERLIS	1.12
WP PUTRAJAYA	1.01
SELANGOR	1.01
WP KUALA LUMPUR	1.00
JOHOR	1.00
PULAU PINANG	1.00
WP LABUAN	0.98
MELAKA	0.98
PAHANG	0.98
KEDAH	0.98
PERAK	0.96
SABAH	0.95
KELANTAN	0.95
TERENGGANU	0.93
NEGERI SEMBILAN	0.92
SARAWAK	0.74
MALAYSIA	0.96

seribulan

BlackOpium

seribulan replied at 3-12-2021 04:15 PM
Balik rumah...tanggal baju...basuh...bla bla bla tu...

Tadi baca kat ig katanya kes kat Perak tu semuanya negative. Budaknya pun dah sihat.
Dah pening baca cerita bercampur ni huhu..

seribulan

BlackOpium replied at 4-12-2021 10:02 AM
Tadi baca kat ig katanya kes kat Perak tu semuanya negative. Budaknya pun dah sihat.
Dah pening ba ...

Haah...baca jugak...ni femili abang & kakak nak mai...nak berkelah ayo terjun...huhu...

BlackOpium

seribulan replied at 4-12-2021 11:50 AM
Haah...baca jugak...ni femili abang & kakak nak mai...nak berkelah ayo terjun...huhu...

Enjoy your weekend kaka seri! Weekend ni iols terperuk je dekat rumah. Takde plan nak pergi mana2 huhu..

seribulan

BlackOpium replied at 4-12-2021 11:35 AM
Enjoy your weekend kaka seri! Weekend ni iols terperuk je dekat rumah. Takde plan nak pergi mana2  ...

Ingat nak terperuk gak...derang nak mai lak...dah survey tempat kelah...ni singgah beli ayo nyo  & coconut shake...lps zohor derang mai...

seribulan

BlackOpium replied at 4-12-2021 11:35 AM
Enjoy your weekend kaka seri! Weekend ni iols terperuk je dekat rumah. Takde plan nak pergi mana2  ...

Lambat info...ni je yg ada...

Kementerian Kesihatan Malaysia (KKM) ingin memaklumkan status terkini kes COVID-19 di Malaysia sehingga 4 Disember 2021 (jam 12:00 tengah hari);

• Kes sembuh : 4,676 kes (2,561,230 kes kumulatif, 96.5%);
• Kes baharu : 4,896 kes (2,654,474 kes kumulatif);
• Kes import : 18 kes (13 warganegara; 5 bukan warganegara);
• Kes tempatan : 4,878 kes [4,675 warganegara (95.8%); 203 bukan warganegara (4.2%)];
• Kes yang memerlukan rawatan di Unit Rawatan Rapi (ICU) : 490 kes (358 kes disahkan COVID-19 ;  132  kes disyaki, kemungkinan, dan kes dalam siasatan);
• Kes memerlukan bantuan pernafasan : 269 kes (155 kes disahkan COVID-19 ; 114 kes disyaki, kemungkinan, dan kes dalam siasatan);
• Jumlah kluster : 5,969 kluster;
• Jumlah kluster baharu : 4 kluster;
• Jumlah kluster yang telah tamat : 5,742 kluster; dan
• Jumlah kluster aktif : 227 kluster.
  

Daripada 4,896 kes harian yang dilaporkan pada hari ini;

• 79 kes (1.6 peratus) adalah kategori 3, 4, dan 5; dan
• 4,817 kes (98.4 peratus) lagi adalah terdiri daripada kategori 1 dan 2.
  

Perincian nilai RT mengikut negeri adalah seperti di Lampiran 1 yang disertakan bersama kenyataan media ini. Manakala, maklumat terperinci lain berkenaan situasi semasa jangkitan dan penularan COVID-19 di Malaysia akan dimuatnaik ke laman web COVIDNOW di https://covidnow.moh.gov.my. Data akan dikemaskini pada jam 12:00 tengah malam setiap hari.

NASIHAT KESIHATAN BERKAITAN COVID-19

KKM juga ingin menasihati orang ramai termasuk individu-individu yang telah menerima vaksin COVID-19 agar terus mematuhi saranan serta nasihat-nasihat kesihatan yang sering ditekankan iaitu;

• Elakkan 3S: (elakkan kawasan yang sesak, sempit dan sembang dengan jarak yang dekat);
• Amalkan 3W: (Amalkan Wash, Wear dan Warn); dan
• Sentiasa memakai pelitup muka di kawasan awam yang tertutup. Pemakaian pelitup muka berganda adalah digalakkan.
  

Patuhlah kepada Prosedur Operasi Standard (SOP) sebagai norma baharu dan dapatkan vaksin COVID-19 bagi mengurangkan risiko jangkitan yang serius, bilangan kes kematian sekaligus membina imuniti kelompok. Dengan pengambilan vaksin, kita dapat melindungi orang di sekeliling daripada kemungkinan jangkitan COVID-19. Dengan imuniti kelompok yang terbentuk, kumpulan yang belum layak diberi imunisasi seperti kanak-kanak dapat dilindungi. Perlindungan untuk semua bermula daripada diri kita.

KKM akan terus memantau perkembangan kejadian jangkitan di dalam negara, dan juga luar negara melalui maklumat yang diperolehi daripada pihak WHO. KKM akan memastikan langkah pencegahan dan kawalan yang sewajarnya dilaksanakan secara berterusan.

Sekian, terima kasih.

TAN SRI DATO’ SERI DR. NOOR HISHAM ABDULLAH

KETUA PENGARAH KESIHATAN MALAYSIA

4 Disember 2021 @ 6:30 petang.

LAMPIRAN 1

NILAI RT MENGIKUT NEGERI

BERDASARKAN KES YANG DILAPORKAN

PADA 3 DISEMBER 2021

NEGERI	NILAI R[size=12.375px]T
PERLIS	1.16
SELANGOR	1.01
WP KUALA LUMPUR	1.01
JOHOR	0.99
PULAU PINANG	0.99
KEDAH	0.99
MELAKA	0.98
PAHANG	0.98
PERAK	0.97
WP PUTRAJAYA	0.95
WP LABUAN	0.94
SABAH	0.94
KELANTAN	0.94
TERENGGANU	0.94
NEGERI SEMBILAN	0.94
SARAWAK	0.73
MALAYSIA	0.97

seribulan

Kes baharu COVID-19 Selangor 4.12.2021 sehingga 12.00 tengahari – 1347 kes (1330 komuniti, 12 penjara, 5 import A)

???? GOMBAK 176
Batu 66
Saringan Bergejala 8
Saringan Kontak Rapat 57
Saringan Pekerja 1
Hulu Kelang 26
Saringan Bergejala 3
Saringan Kontak Rapat 23
Kuang 27
Saringan Bergejala 3
Saringan Kontak (Kluster Lorong Melati) 1
Saringan Kontak Rapat 23
Rawang 29
Saringan Bergejala 5
Saringan Kontak Rapat 22
Saringan Pekerja 2
Setapak 28
Saringan Bergejala 8
Saringan Kontak Rapat 20
???? HULU LANGAT 344
Ampang 60
Saringan Bergejala 14
Saringan Kontak (Kluster Industri Persiaran Usahawan Tiga 2) 1
Saringan Kontak Rapat 45
Beranang 11
Saringan Bergejala 5
Saringan Kontak Rapat 6
Cheras 55
Saringan Bergejala 18
Saringan Kendiri 1
Saringan Kontak Rapat 33
Saringan Pekerja (Kluster Industri Jln Cheras Jaya 1/6) 3
Hulu Langat 16
Saringan Bergejala 4
Saringan Kontak Rapat 12
Kajang 144
Saringan Bergejala 34
Saringan Bergejala (Kluster Industri Dua Jln Sepuluh MIEL) 1
Saringan Bergejala (Kluster Industri Persiaran Usahawan Tiga 2) 1
Saringan Kontak (Kluster Industri Dua Jln Sepuluh MIEL) 1
Saringan Kontak (Kluster Industri Jln P1/1 Bangi) 1
Saringan Kontak (Kluster Industri Persiaran Kemajuan) 1
Saringan Kontak (Kluster Persiaran Tasik) 3
Saringan Kontak Rapat 100
Saringan Pekerja 1
Saringan Pre-Admission 1
Semenyih 45
Saringan Bergejala 14
Saringan Kontak (Kluster Persiaran Tasik) 1
Saringan Kontak Rapat 30
Penjara 8
Saringan OKT 8
Import A (Arab Saudi) 1
Import A (Pakistan) 1
Import A (Turki) 1
Import A (USA) 2
???? HULU SELANGOR 59
Batang Kali 5
Saringan Bergejala 1
Saringan Kontak Rapat 4
Hulu Bernam 10
Saringan Kontak Rapat 10
Hulu Yam 1
Saringan Kontak Rapat 1
Kalumpang 4
Saringan Kontak Rapat 4
Kerling 7
Saringan Kontak Rapat 7
Rasa 2
Saringan Kontak Rapat 2
Serendah 30
Saringan Kontak Rapat 30
???? KLANG 191
Kapar 60
Saringan Bergejala 26
Saringan Kontak Rapat 31
Saringan Pekerja 3
Klang 131
Saringan Bergejala 43
Saringan Bergejala (Kluster Industri Fasa 2A Indah) 1
Saringan Kontak (Kluster Industri Fasa 2A Indah) 2
Saringan Kontak (Kluster Jln Hamzah) 1
Saringan Kontak Rapat 63
Saringan Pekerja 12
Saringan Pekerja (Kluster Industri Fasa 2A Indah) 2
Saringan Postmortem 1
Saringan Pra-Penerbangan 1
Saringan Pra-Prosedur 2
Saringan SARI 3
???? KUALA LANGAT 69
Batu 5
Saringan Bergejala 1
Saringan Kontak Rapat 4
Tanjung 12 (1) 30
Saringan Bergejala 8
Saringan Kontak (Kluster Industri Dua Jln Lapan Olak) 1
Saringan Kontak Rapat 18
Saringan Pekerja 2
Saringan Pekerja (Kluster Industri Dua Jln Lapan Olak) 1
Tanjung 12 (2) 7
Saringan Bergejala 2
Saringan Kontak (Kluster Industri Dua Jln Lapan Olak) 2
Saringan Kontak Rapat 3
Telok Panglima Garang 23
Saringan Bergejala 7
Saringan Kontak Rapat 11
Saringan Pekerja 5
Penjara 4
Saringan OKT 4
???? KUALA SELANGOR 91
Api - Api 1
Saringan Bergejala 1
Bestari Jaya 11
Saringan Bergejala 2
Saringan Kendiri 3
Saringan Kontak Rapat 5
Saringan Pekerja (Kluster Industri Alam Jaya 2/4) 1
Ijok 38
Saringan Bergejala 12
Saringan Kendiri 4
Saringan Kontak Rapat 21
Saringan Pra-Pekerjaan 1
Jeram 8
Saringan Bergejala 2
Saringan Kontak Rapat 5
Saringan Pekerja 1
Kuala Selangor 12
Saringan Bergejala 4
Saringan Kendiri 1
Saringan Kontak Rapat 7
Tanjung Karang 21
Saringan Bergejala 4
Saringan Kontak Rapat 17
???? PETALING 297
Bukit Raja 32
Saringan Bergejala 10
Saringan Kontak (Kluster Jln Hamzah) 4
Saringan Kontak Rapat 18
Damansara 94
Saringan Bergejala 40
Saringan Kendiri 1
Saringan Kontak Rapat 51
Saringan Pekerja 1
Saringan Pre-Admission 1
Petaling 109
Saringan Bergejala 43
Saringan Kontak (Kluster Persiaran Tasik) 1
Saringan Kontak Rapat 57
Saringan Pekerja 6
Saringan Pra-Penerbangan 1
Saringan Pre-Admission 1
Sungai Buloh 62
Saringan Bergejala 17
Saringan Kontak Rapat 39
Saringan Pekerja 6
???? SABAK BERNAM 37
Bagan Nakhoda Omar 6
Saringan Bergejala (Kluster Jln Semenanjung Bernam Tiga) 3
Saringan Kontak (Kluster Industri Batu 14 1/2 Panchang Bedena) 1
Saringan Kontak Rapat 1
Saringan SARI 1
Panchang Bedena 11
Saringan Bergejala 5
Saringan Kendiri 2
Saringan Kontak (Kluster Industri Batu 4 1/2 Panchang Bedena) 1
Saringan Kontak (Kluster Jln Pegawai) 1
Saringan Kontak Rapat 2
Pasir Panjang 8
Saringan Bergejala 5
Saringan Bergejala (Kluster Industri Batu 4 1/2 Panchang Bedena) 1
Saringan Kendiri 1
Saringan Kontak Rapat 1
Sabak 9
Saringan Bergejala 1
Saringan Kontak (Kluster Industri Batu 4 1/2 Panchang Bedena) 1
Saringan Kontak Rapat 7
Sungai Panjang 3
Saringan Bergejala 1
Saringan Kontak Rapat 2
???? SEPANG 83
Dengkil 47
Saringan Bergejala 1
Saringan Kendiri 1
Saringan Kontak (Kluster Persiaran Tasik) 15
Saringan Kontak Rapat 30
Labu 25
Saringan Bergejala 1
Saringan Kontak (Kluster Persiaran Tasik) 2
Saringan Kontak Rapat 22
Sepang 11
Saringan Kendiri 1
Saringan Kontak Rapat 10

seribulan

BlackOpium replied at 3-12-2021 03:08 PM
Rasanya ada terbaca jugak kat SA tu macam biasa je. Kes variant baru pun doktor rileks je suruh pa ...

Hari ni...baru balik berkelah...area jeram yg x ramai orang

seribulan

Pada 5 Disember 2021, jumlah kes COVID-19 yang dilaporkan adalah 4,298 kes menjadikan jumlah kumulatif sebanyak 2,658,772 kes.
Maklumat terperinci akan dimuatnaik ke laman COVIDNOW.moh.gov.my
Data setiap hari bagi laman COVIDNOW adalah dikemaskini sekaligus selepas tengah malam.

seribulan

Kes baharu COVID-19 Selangor 5.12.2021 sehingga 12.00 tengahari – 1160 kes (1149 komuniti, 11 penjara)

✅ GOMBAK 102
Batu 45
Saringan Bergejala 4
Saringan Kontak Rapat 37
Saringan Pekerja 2
Saringan Postmortem 2
Hulu Kelang 5
Saringan Bergejala 1
Saringan Kontak Rapat 4
Kuang 4
Saringan Bergejala 1
Saringan Kontak Rapat 3
Rawang 26
Saringan Bergejala 1
Saringan Kontak Rapat 24
Saringan Pekerja 1
Setapak 22
Saringan Kontak Rapat 22
✅ HULU LANGAT 319
Ampang 61
Saringan Bergejala 16
Saringan Bergejala (Kluster Industri Jln P1/1 Bangi) 1
Saringan Kontak Rapat 44
Beranang 12
Saringan Bergejala 2
Saringan Kontak (Kluster Industri Jln Perusahaan Empat) 2
Saringan Kontak Rapat 8
Cheras 62
Saringan Bergejala 16
Saringan Kendiri 1
Saringan Kontak Rapat 44
Saringan SARI 1
Hulu Langat 14
Saringan Bergejala 4
Saringan Kontak Rapat 10
Kajang 136
Saringan Bergejala 39
Saringan Bergejala (Kluster Industri Dua Jln Sepuluh MIEL) 1
Saringan Bergejala (Kluster Industri Jln P1/1 Bangi) 2
Saringan Kendiri 1
Saringan Kontak Rapat 90
Saringan Pekerja 3
Semenyih 25
Saringan Bergejala 3
Saringan Kendiri 1
Saringan Kontak Rapat 21
Penjara 9
Saringan OKT 9
✅ HULU SELANGOR 56
Ampang Pechah 6
Saringan Kontak Rapat 6
Batang Kali 9
Saringan Bergejala 1
Saringan Kontak Rapat 8
Hulu Yam 3
Saringan Bergejala 1
Saringan Kontak Rapat 2
Kerling 2
Saringan Kontak Rapat 2
Rasa 8
Saringan Bergejala 1
Saringan Kontak Rapat 7
Serendah 28
Saringan Kontak Rapat 26
Saringan Pekerja 2
✅ KLANG 216
Kapar 47
Saringan Bergejala 9
Saringan Kendiri 1
Saringan Kontak Rapat 36
Saringan Pekerja 1
Klang 169
Saringan Bergejala 44
Saringan Kontak Rapat 113
Saringan Pekerja 11
Saringan Pra-Penerbangan 1
✅ KUALA LANGAT 75
Bandar 4
Saringan Bergejala 1
Saringan Kontak Rapat 1
Saringan Pekerja 1
Saringan Pre-Admission 1
Batu 5
Saringan Bergejala 3
Saringan Kontak Rapat 1
Saringan Pekerja 1
Jugra 1
Saringan Bergejala 1
Morib 4
Saringan Bergejala 3
Saringan Pekerja 1
Tanjung 12 (1) 20
Saringan Bergejala 13
Saringan Kontak Rapat 6
Saringan Pekerja (Kluster Industri Dua Jln Lapan Olak) 1
Tanjung 12 (2) 21
Saringan Bergejala 12
Saringan Kontak Rapat 6
Saringan Pekerja 3
Telok Panglima Garang 20
Saringan Bergejala 9
Saringan Kontak Rapat 9
Saringan Pekerja 2
✅ KUALA SELANGOR 43
Ijok 27
Saringan Bergejala 14
Saringan Kendiri 1
Saringan Kontak Rapat 11
Saringan Pekerja 1
Jeram 5
Saringan Bergejala 3
Saringan Kontak Rapat 2
Kuala Selangor 4
Saringan Bergejala 1
Saringan Kontak Rapat 2
Saringan Pekerja 1
Tanjung Karang 7
Saringan Bergejala 4
Saringan Kontak Rapat 3
✅ PETALING 208
Bukit Raja 43
Saringan Bergejala 18
Saringan Kontak (Kluster Jln Hamzah) 10
Saringan Kontak Rapat 15
Damansara 70
Saringan Bergejala 34
Saringan Kendiri 3
Saringan Kontak Rapat 31
Saringan Pekerja 2
Petaling 60
Saringan Bergejala 27
Saringan Kendiri 1
Saringan Kontak Rapat 28
Saringan Pekerja 1
Saringan SARI 3
Sungai Buloh 35
Saringan Bergejala 20
Saringan Kontak Rapat 15
✅ SABAK BERNAM 44
Panchang Bedena 25
Saringan Bergejala 12
Saringan Bergejala (Kluster Industri Batu 4 1/2 Panchang Bedena) 3
Saringan Kendiri 2
Saringan Kontak (Kluster Industri Batu 4 1/2 Panchang Bedena) 1
Saringan Kontak Rapat 7
Pasir Panjang 10
Saringan Bergejala 4
Saringan Kendiri 1
Saringan Kontak Rapat 5
Sabak 8
Saringan Bergejala 3
Saringan Bergejala (Kluster Industri Batu 4 1/2 Panchang Bedena) 1
Saringan Kendiri 2
Saringan Kontak Rapat 2
Sungai Panjang 1
Saringan Kontak (Kluster Industri Batu 4 1/2 Panchang Bedena) 1
✅ SEPANG 97
Dengkil 67
Saringan Bergejala 21
Saringan Bergejala (Kluster Industri Jln Labohan Dagang-Nilai) 1
Saringan Bergejala (Kluster Persiaran Semarak) 1
Saringan Kontak (Kluster Industri Jln Labohan Dagang-Nilai) 3
Saringan Kontak (Kluster Persiaran Tasik) 1
Saringan Kontak Rapat 39
Saringan Pekerja 1
Labu 16
Saringan Bergejala 5
Saringan Bergejala (Kluster Jln Labohan) 1
Saringan Kontak Rapat 9
Saringan Pekerja 1
Sepang 12
Saringan Bergejala 1
Saringan Kontak Rapat 10
Saringan Pekerja 1
Penjara 2
Saringan OKT 2

seribulan

Kementerian Kesihatan Malaysia (KKM) ingin memaklumkan status terkini kes COVID-19 di Malaysia sehingga 5 Disember 2021 (jam 12:00 tengah hari);

• Kes sembuh : 4,929 kes (2,566,159) kes kumulatif, 96.5%);
• Kes baharu : 4,298 kes (2,658,772 kes kumulatif);
• Kes import : 23 kes (19 warganegara; 4 bukan warganegara);
• Kes tempatan : 4,275 kes[4,125 warganegara (96.5%); 150 bukan warganegara (3.5%)];
• Kes yang memerlukan rawatan di Unit Rawatan Rapi (ICU) : 471 kes (378 kes disahkan COVID-19 ;  93  kes disyaki, kemungkinan, dan kes dalam siasatan);
• Kes memerlukan bantuan pernafasan : 264 kes (172 kes disahkan COVID-19 ; 92 kes disyaki, kemungkinan, dan kes dalam siasatan);
• Jumlah kluster : 5,978 kluster;
• Jumlah kluster baharu : 9 kluster;
• Jumlah kluster yang telah tamat : 5,745 kluster; dan
• Jumlah kluster aktif : 233 kluster.
  

Daripada 4,298 kes harian yang dilaporkan pada hari ini;

• 75 kes (1.7 peratus) adalah kategori 3, 4, dan 5; dan
• 4,223 kes (98.3 peratus) lagi adalah terdiri daripada kategori 1 dan 2.
  

Perincian nilai RT mengikut negeri adalah seperti di Lampiran 1 yang disertakan bersama kenyataan media ini. Manakala, maklumat terperinci lain berkenaan situasi semasa jangkitan dan penularan COVID-19 di Malaysia akan dimuatnaik ke laman web COVIDNOW di https://covidnow.moh.gov.my. Data akan dikemaskini pada jam 12:00 tengah malam setiap hari.

NASIHAT KESIHATAN BERKAITAN COVID-19

KKM juga ingin menasihati orang ramai termasuk individu-individu yang telah menerima vaksin COVID-19 agar terus mematuhi saranan serta nasihat-nasihat kesihatan yang sering ditekankan iaitu;

• Elakkan 3S: (elakkan kawasan yang sesak, sempit dan sembang dengan jarak yang dekat);
• Amalkan 3W: (Amalkan Wash, Wear dan Warn); dan
• Sentiasa memakai pelitup muka di kawasan awam yang tertutup. Pemakaian pelitup muka berganda adalah digalakkan.
  

Patuhlah kepada Prosedur Operasi Standard (SOP) sebagai norma baharu dan dapatkan vaksin COVID-19 bagi mengurangkan risiko jangkitan yang serius, bilangan kes kematian sekaligus membina imuniti kelompok. Dengan pengambilan vaksin, kita dapat melindungi orang di sekeliling daripada kemungkinan jangkitan COVID-19. Dengan imuniti kelompok yang terbentuk, kumpulan yang belum layak diberi imunisasi seperti kanak-kanak dapat dilindungi. Perlindungan untuk semua bermula daripada diri kita.

KKM akan terus memantau perkembangan kejadian jangkitan di dalam negara, dan juga luar negara melalui maklumat yang diperolehi daripada pihak WHO. KKM akan memastikan langkah pencegahan dan kawalan yang sewajarnya dilaksanakan secara berterusan.

Sekian, terima kasih.

TAN SRI DATO’ SERI DR. NOOR HISHAM ABDULLAH

KETUA PENGARAH KESIHATAN MALAYSIA

5 Disember 2021 @ 6:30 petang.

LAMPIRAN 1

NILAI RT MENGIKUT NEGERI

BERDASARKAN KES YANG DILAPORKAN

PADA 4 DISEMBER 2021

NEGERI	NILAI R[size=12.375px]T
PERLIS	1.16
SELANGOR	1.00
WP LABUAN	1.00
WP KUALA LUMPUR	0.99
JOHOR	0.99
PULAU PINANG	0.99
KEDAH	0.99
MELAKA	0.98
PERAK	0.98
PAHANG	0.97
NEGERI SEMBILAN	0.96
SABAH	0.93
KELANTAN	0.93
TERENGGANU	0.93
WP PUTRAJAYA	0.89
SARAWAK	0.73
MALAYSIA	0.97

farhana008

seribulan replied at 1-12-2021 11:20 AM
Khabarnya sorang pelancong derang terlepas masuk Mesia...huhu...

Hari tu kkm nafi ada varian Omicron kat perak.sekali betul2 ada!

seribulan

farhana008 replied at 5-12-2021 06:04 PM
Hari tu kkm nafi ada varian Omicron kat perak.sekali betul2 ada!

Tu le pasal...siap kata palsu kat org yg tanya...rupanya coverline, kome...huhu...